Loading...

MBOT MICROBOT MEDICAL INC US FDA Inspections 8-K Filing

MCRB

MBT

MICROBOT MEDICAL INC

(MBOT)

2024 8-K

Show Summary

Show Summary

Equity Offerings

Equity Offerings

Product Expansion

Market Expansion

Presentation Materials

Equity Offerings

Annual Meeting Update

By-law Amendment

Trial Data Announcement

Management Change

Research Collaboration

Capital Raise Update

Management Changes

Conference Announcement

Nasdaq Compliance

CEO Bonus Approval

Management Appointment

Commercial Launch Prep

Director Appointment

Presentation Update

Clinical Trial Update

Nasdaq Compliance Notice

Clinical Trial Update

Clinical Trial Update

Presentation Update

Collaboration Agreement

ISO Certification

Collaboration Agreement

Clinical Trial Enrollment

Clinical Trial Update

Clinical Trial Agreement wi...

Shelf Registration Statemen...

Clinical Trial Participation

Securities Purchase Agreements

FDA Approval for Clinical T...

Collaboration Completion

Presentation Materials

Entry into a Material Defin...

Addition of Clinical Resear...

Reinstatement of Fees and C...

Investment Options Exercise

Collaboration Agreement

Other Special Situation

Disruption of Operations

Appointment of Chief Medica...

Compensation Reinstatement

Trademark Granted

Annual Meeting of Stockholders

Positive Study Outcomes

Partnership with CRO

Manufacturing Agreement

Expansion of Global Team

Market Expansion

Announcement of Pre-Clinica...

Securities Purchase Agreements

Expansion of IP Portfolio

Securities Purchase Agreements

Announcement of Formative S...

Announcement of Human Trial...

Securities Purchase Agreement

Securities Purchase Agreement

Cost Restructuring and Pre-...

Preparations for First-In-H...

Animal Study Results

External Links:

Microbot Medical Inc. received FDA approval for its clinical trial of the LIBERTY Endovascular Robotic Surgical System.

AI Assistant

MICROBOT MEDICAL INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.